O. B. O. C. C. Group

The economic costs of Group B Streptococcus (GBS) disease: prospective cohort study of infants with GBS disease in England

S. Petrou, P. Heath, E. Schroeder, 2008, The European Journal of Health Economics.

δF508 heterozygosity and asthma

A. Kitzis, F. Kauffmann, J. Feingold, 1998, The Lancet.

Global health learning outcomes for medical students in the UK

T. Crocker-Buque, O. Johnson, O. B. O. C. C. Group, 2012, The Lancet.

Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data

J. Bourhis, Christian Domenge, JP Pignon, 2000, The Lancet.

The way forward

J. Cleland, C. AbouZahr, S. Macfarlane, 2007, The Lancet.